NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research. The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA. It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.
Funding Agency: NIH
Deadline: November 6, 2019
Amount: $600,000
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-349.html
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.
Funding Agency: NIH
Deadline: July 16, 2022
Amount: $50,000
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-347.html
Investigations on Primary Immunodeficiency Disease/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to support the discovery and characterization of primary immunodeficiency diseases, also referred to as inborn errors of immunity, to understand the causes and mechanisms of disease, to enable early detection and molecular diagnosis, and to support the development of strategies to treat and eventually cure these disorders.
Funding Agency: NIH
Deadline: September 7, 2022
Amount: $200,000
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-346.html
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) announces the availability of support for collaborative research by multi-disciplinary teams which is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches. The NIDA Program Projects funding opportunity will support research in which the funding of three or more highly meritorious projects as a group enriches both the component projects and the overall program to offer significant scientific advantages over supporting the same projects as individual research grants (i.e., synergy). For the duration of the award, each Program must consist of a minimum of three research projects focused on issues critical to advance the mission and goals of NIDA.
Funding Agency: NIH
Deadline: September 7, 2022
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-345.html
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication pilot interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.
Funding Agency: NIH
Deadline: June 8, 2022
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-350.html
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer communication: 1) the utility and application of new cancer communication surveillance approaches; 2) the development and testing of rapid cancer communication interventions using innovative methods and designs; and 3) the development and testing of multilevel cancer communication models emphasizing bidirectional influence between levels. For such projects, applicants should apply communication science approaches to the investigation of behavioral targets and health outcomes related to cancer prevention and control. Applications should utilize one or more innovative communication research methodologies.
Funding Agency: NIH
Deadline: June 8, 2022
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-348.html
YSEALI Boot Camp 2020
The Public Affairs Section of the U.S. Embassyin Kuala Lumpur announces an open competition for organizations to submitapplications to implement a series of boot camp programs on youth empowermentand leadership for members of the Young Southeast Asian Leaders Initiative(YSEALI) in higher education institutions throughout Malaysia. The U.S. Embassy Kuala Lumpur will have arole in determining the content and structure of the boot camps. Proposals aresubject to funding availability.
Funding Agency: U.S. Mission to Malaysia
Deadline: September 17, 2019
Amount: $100,000
For more information: Go to grants.gov and search for opportunity # SMY300-19-YSEALI-BOOTCAMP
Fiscal Year 2020 Consolidated Innovative Nuclear Research
The Department of Energy’s (DOE) Office of Nuclear Energy’s (NE) mission is to advance U.S. nuclear power in order to meet the nation’s energy needs by:
1.) Enhancing the long-term viability and competitiveness of the existing U.S. reactor fleet;
2.) Developing an advanced reactor pipeline; and,
3.) Implementing and maintaining the national strategic fuel cycle and supply chain infrastructure.
All applications submitted under this FOA must demonstrate a strong tie to at least one of these 3 priorities.
NE conducts crosscutting nuclear energy research and development (R&D) and associated infrastructure support activities, to develop innovative technologies that offer the promise of dramatically improved performance for its mission needs as stated above, while maximizing the impact of DOE resources.
The DOE has established a Gateway for Accelerated Innovation in Nuclear (GAIN) team, which has been working closely with the advanced nuclear design community to identify R&D objectives and work scopes that may be appropriately addressed through DOE programs. Several of the work scopes contain explicit language as guidance, but there are many additional work scopes that, at least tangentially, address needs identified in technology specific workshops. Work scopes that may be addressed in activities funded under this FOA are identified in Part IX, Appendices A-C, below. Generally speaking, applications that offer flexibility or provision for addressing measurements, materials, and conditions relevant to private sector developers of fast-spectrum reactors (lead-cooled, sodium cooled, and gas cooled), molten salt reactors (MSR), or high-temperature gas-cooled reactors (HTGCR) are encouraged.
NE strives to promote integrated and collaborative research conducted by national laboratory, university, industry, and international partners under the direction of NE’s programs, and to deploy innovative nuclear energy technologies to the market in order to meet the strategic goals and optimize the benefits of nuclear energy. NE funds research activities, through both competitive and direct mechanisms, as required to best meet the needs of NE. This approach ensures a balanced R&D portfolio and encourages new nuclear power deployment with creative solutions to the universe of nuclear energy challenges. This FOA addresses the competitive portion of NE’s R&D portfolio, as executed through the Nuclear Energy University Program (NEUP), Nuclear Energy Enabling Technologies (NEET) Crosscutting Technology Development (CTD), and the Nuclear Science User Facilities (NSUF). NEUP utilizes up to 20% of funds appropriated to NE’s R&D program for university-based infrastructure support and R&D in key NE program-related areas: Fuel Cycle Research and Development (FC R&D), Reactor Concepts Research, Development and Demonstration (RC RD&D), and Nuclear Energy Advanced Modeling and Simulation (NEAMS). NEET CTD supports national laboratory and university-led crosscutting research. By establishing the NSUF in 2007, DOE-NE opened up access to material test reactors, beam lines, and post-irradiation examination facilities to researchers from U.S. universities, industry, and national laboratories, by granting no-cost access to world-class nuclear research facilities.
While this FOA specifies many of NE’s current and upcoming R&D priorities, NE reserves the right to respond to potential shifts in R&D priorities during Fiscal Year (FY) 2020 that may be driven by events, policy developments, or Congressional/budget direction. Further, NE reserves the right to fund all or part of an application to this FOA.
Funding Agency: Idaho Field Office
Deadline: February 12, 2020
Amount: $1,000,000
For more information: https://neup.inl.gov/SitePages/Home.aspx
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Exploratory and Developmental Research Grant (R21) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R21 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R21 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.
Funding Agency: NIH
Deadline: September 7, 2020
Amount: $200,000
For more information: https://grants.nih.gov/grants/guide/pa-files/PAR-19-351.html
Scientific Infrastructure Support for Consolidated Innovative Nuclear Research
The Department of Energy’s (DOE) Office of Nuclear Energy (NE) provides funding to support crosscutting nuclear energy research and development (R&D), and associated infrastructure support activities, to develop innovative technologies that offer the promise of dramatically improved performance for advanced reactors and fuel cycle concepts, while maximizing the use of DOE resources.
The development of nuclear energy-related infrastructure and basic capabilities in the research community is necessary to promote R&D that supports nuclear science and engineering (NS&E), DOE-NE’s mission, and the Nation’s nuclear energy challenges. Accordingly, DOE intends to enable the education and training of nuclear scientists, engineers, and policy-makers, in graduate and undergraduate study, and two-year programs, as well as R&D that is relevant to the Department and the nuclear energy industry in general.
The Nuclear Energy University Program (NEUP) utilizes up to 20 percent of funds appropriated to NE’s R&D program for university-based infrastructure support and R&D in key NE program-related areas:
- Fuel Cycle Research and Development (FC R&D)
- Reactor Concepts Research, Development and Demonstration (RC RD&D)
- Nuclear Energy Advanced Modeling and Simulation (NEAMS)
The infrastructure requested should be individual, discrete, and definable items or capabilities that will:
- Support, maintain, or enhance the institutions’ capacities to attract and teach high quality students interested in nuclear energy-related studies;
- Build the institutions’ research or education capabilities; or
- Enhance the institutions’ capabilities to perform R&D that is relevant to DOE-NE’s mission.
NE reserves the right to respond to potential shifts in priorities during FY 2020 that may be driven by events, policy developments, or Congressional/budget direction. NE will factor such considerations into decisions related to the timing and scale of award announcements associated with this FOA.
Funding Agency: Idaho Field Office
Deadline: November 14, 2019
Amount: $5,000,000
For more information: https://neup.inl.gov/SitePages/Home.aspx
Family Self-Sufficiency and Stability Research Scholars Network
This announcement’s synopsis has been updated. The Office of Planning, Research, and Evaluation (OPRE) within the Administration for Children and Families (ACF) in the Department of Health and Human Services (HHS) invites applications from eligible entities to apply for funds to support a social science researcher (the proposed Principal Investigator) to become a member of the Family Self-Sufficiency and Stability Research Network (the Network). The goal of the Network is to support productive partnerships between social science scholars and state or local human services agencies. As such, applicants are required to demonstrate a partnership or potential partnership with one or more state or local human services agency responsible for administering benefits or programming to assist and support family self-sufficiency, including close coordination with the agency responsible for administering the Temporary Assistance for Needy Families (TANF) program, as an integral part of their research plan development and execution. In addition to supporting the proposed Principal Investigator (PI) to pursue their individual programs of rigorous and relevant research, entities must also support PIs in participating in a multidisciplinary learning community by collaborating with other members of the Network funded under this announcement. For more information on the previous cohort of scholars and their work, please see: https://www.acf.hhs.gov/opre/resource/family-self-sufficiency-and-stability-scholars-2013-grantees and the most recent year-in-review: https://www.acf.hhs.gov/opre/resource/family-self-sufficiency-and-stability-research-consortium-year-in-review-2017. Initial awards will be made for the first 12-month budget period; annual continuation awards for the four remaining 12-month budget periods will be awarded subject to the availability of funds, satisfactory progress by the grantee, and a determination that continued funding would be in the interest of the federal government.
Funding Agency: Administration for Children and Families – OPRE
Deadline: October 21, 2019
Amount: $100,000
For more information: https://ami.grantsolutions.gov/HHS-2020-ACF-OPRE-PE-1571
Inventory and Assessment of NPS Alaska Archaeological Collections at the Haffenreffer Museum of Anthropology, Brown University
Archeological field research on federal lands in Alaska were conducted under federal permits by representatives of Brown University as far back as the 1940s. These nationally significant collections are, and remain, the type collections for the Western Arctic, as well as the archived life’s work of two of the Western Arctic’s scientific pioneers-Louis Giddings and Doug Anderson. Cape Krusenstern and Kobuk Valley were established in part due to this archaeological work. As was common then, and currently an option, non-federal repositories such as the Haffenreffer Museum have cared for artifacts and samples collected under federal permit. Objectives: Developing Baseline Documentation: This project will provide a physical inventory and update to the museum database. Archeological collections obtained from federal lands remain the property of the federal government in perpetuity. Transferring Knowledge: Documentation will be given to park management and cultural resource staff to make the best decisions on long-term preservation, conservation needs, and access issues to non-federal institutions by researchers. Native American Graves Protection and Repatriation Act (NAGPRA) Compliance: This project may locate items subject to NAGPRA since it will inventory archeological collections. The objective of this Agreement is to conduct a comprehensive inventory of archeological collections in the care of the Haffenreffer Museum that originate from federal lands in Alaska currently administered by the National Park Service. During the course of the inventory, assessment of the condition of items will also be completed. The resultant inventory will allow NPS to establish formal museum object loans with the Haffenreffer Museum to adequately track, manage and support their long-term care.
Funding Agency: National Park Service
Deadline: August 31, 2019
Amount: $560,530
For more information: Got to grants.gov and search opportunity # P19AS00574
Combating Opioid Overdose through Community Level Intervention
The opioid epidemic continues throughout the United States, claiming an alarming number of lives each year. Drug overdose is now the leading cause of injury death in the United States, surpassing motor vehicle crashes since 2009. According to provisional data released by the Centers for Disease Control and Prevention (CDC), reported drug overdoses accounted for more than 67,000 U.S. deaths in 2018 and, of those, more than 47,000(69%) involved an opioid. This ongoing opioid overdose epidemic presents new challenges to public health and public safety officials, medical professionals, local communities, and other stakeholders invested in curbing rates of accidental death. Preparing regional and community leaders to respond effectively to the public health emergency that is today’s opioid overdose crisis (and be prepared to take on that crisis as it evolves tomorrow) is essential for achieving the shared goal of preventing fatal overdose and saving lives. To aid this effort, on October 26, 2017, President Trump asked the Acting Secretary of the Department of Health and Human Services to declare the opioid crisis a national Public Health Emergency under Federal law and directed all executive agencies to use every appropriate emergency authority to fight the opioid crisis.
ONDCP expects to award one Federal cooperative agreement under the Combating Opioid Overdose through Community-Level Intervention Initiative for a 1-year period, beginning approximately September 2019. The successful non-Federal entity (NFE) will conduct research activities that entail implementing and evaluating community-based efforts to fight the opioid-involved overdose epidemic. These activities will be focused on the regions of the United States with some of the highest rates of fatal and non-fatal opioid-related overdoses and will work to coordinate the often decentralized state and local efforts to assess and respond to opioid-related overdoses.
Efforts will also support and promote the partnership of law enforcement and public health agencies, as coordination and collaboration between these two groups is proving critical to addressing this epidemic. Efforts will also align with and be informed by related projects currently being conducted by ONDCP and CDC, and both agencies will work closely with the successful NFE. In particular, work conducted under this initiative will entail partnership with Federally designated High Intensity Drug Trafficking Areas (HIDTA) program, which are funded by ONDCP and currently partner with the CDC under the Overdose Response Strategy initiative.
Goals, Objectives and What the Government is Supporting
The assistance provided under this award will support the NFE’s performance of the award and fulfillment of the following performance areas:
- Research and analyze 1) a range of existing community-based efforts to address opioid-involved overdoses and 2) current evidence-based and proven strategies to reduce opioid-related overdose deaths;
- Using the evidence-based approaches previously identified, implement or enhance community-based new or ongoing programs that aim to reduce opioid-involved overdose, particularly in the regions of the United States with the highest rates of fatal and non-fatal opioid overdoses (priority will be given to proposals that make funding available to at least eight communities via subawards);
- Once implemented, support the evaluation of these community-based efforts to assess their efficacy in reducing opioid-involved overdose and other harms of opioid (mis)use, particularly in the regions of the United States with the highest rates of fatal and non-fatal opioid overdoses;
- Support and promote collaboration between public safety and public health agencies to ensure that overdose reduction efforts are aligned and that communities benefit from a comprehensive and coordinated response; and
- Provide technical assistance to support implementation, evaluation, and reporting by prospective subaward recipients.
Funding Agency: Office of National Drug Control Policy
Deadline: September 3, 2019
Amount: $4,500,000
For more information: Go to grants.gov and search for opportunity # COOCLI1